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▼The His·Tag protein purification system enjoys a great
deal of popularity due to its ease of use in rapidly prepar-
ing large amounts of purified protein. The His·Tag system
takes advantage of the affinity of histidine residues for
metal cations, usually divalent cations such as Zn2+, Cu2+,
or Ni2+ (Ref. 1). A stationary support, in this case chelating
Sepharose, is charged with the metal salt of choice. A crude
cell extract is then applied to the column and only proteins
with a high affinity for the divalent cation will bind to the
column. After washing to remove other proteins, the bound
protein is eluted off the column. Most commercial systems
use imidazole as the eluent to remove bound protein from
a column. Alternative approaches for elution have been re-
ported, including lowering the pH or the addition of EDTA
(Ref. 1, 2). Anecdotal evidence suggests that many His·Tag
proteins that retain activity in vivo are inactive in vitro after
elution. The loss of activity with imidazole as the eluent
could be due to an effect on the protein. The use of low pH
might interfere with protein activity by denaturation and
EDTA could be binding important metal co-factors. Here,
we describe a less harsh option for the eluant, L-histidine.
Protocol
The gene that codes for the PutA protein from Salmonella
typhimurium was cloned into pET15b (Novagen). This plas-
mid (pPC113) was introduced into the Escherichia coli strain
BL21λDE3 (Ref. 3) via electroporation (Ref. 4). The result-
ing strain (EM1475) was then grown aerobically at 37◦C to
an OD600 of ∼0.6 and induced with 1 mM IPTG. The cells
were then reincubated at 37◦C for 1 h before harvesting. The
cells were centrifuged at 6000 × g for 10 minutes at 4◦C,
the supernatant was removed, and the cells were washed
Corresponding author: s-maloy@uiuc.edu
with an equal volume of ice-cold 0.85% (w/v) NaCl. After
resuspension in 10 ml of G Buffer (70 mM Tris-HCl pH 8.2,
20% (v/v) glycerol), the cells were then ruptured by two
passes in a French Pres sure cell (SLM/Aminco) at 2000 psi.
Cellular debris was removed by centrifugation at 20,000 ×
g for 20 minutes. The supernatant was saved and, before
loading on the column, it was passed through a 0.45 µm
SFCA filter (Nalgene).
The column used in this studywas a HiTrapMetal Chelat-
ing column (Pharmacia). All chromatography solutions
were filtered and degassed and the column was prepared
by washing with 10 ml of 20% (v/v) glycerol, as described
by themanufacturer. After charging with 2ml of 0.1M Zinc
sulphate, excess Zn2+ was removed by washing with 5 ml of
20% glycerol (v/v). The column was equilibrated with 5 ml
of GA Buffer (70 mM Tris-HCl pH 8.2, 100 mM NaCl, 20%
(v/v) glycerol) and loaded with 3 ml of the crude extract
described above. The column was then attached to an FPLC
system (Pharmacia) and washed with 10 ml of GA Buffer
to remove unbound proteins. After the wash, the His·Tag
PutA protein was eluted with a linear gradient of L-histidine
(0−250mM) in GA Buffer. Typically, PutA eluted at approx-
imately 75 mM L-histidine. After elution, the protein was
concentrated using Centricon concentrators (Amicon).
A comparison to other methods of elution was made and
the results are summarized in (Table 1). Imidazole elution
was carried out according to themanufacturers instructions
(Novagen). Elution by lowering the pH was done in the
same manner as the imidazole elution, with the following
buffer changes: the binding buffer was G Buffer (20% glyc-
erol (v/v) 70 mM Tris-HCl pH 8.2); the wash buffer was
G Buffer pH 7.5; and the elution buffer was G Buffer pH
5.9. The EDTA elution was carried out at the same time as
the pH elution. Then 15 ml Strip Buffer (100 mM EDTA,
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FIGURE 1. Purity of peak elution fractions. Peak-activity fractions
eluted from the alternative procedures were identified by proline
dehydrogenase assays. The peak fractions from each eluent were
separated by SDS PAGE. The gels were scanned and analyzed using the
NIH Image program. The largest peak in each plot (indicated by an
arrow) corresponds to PutA.
500 mM NaCl, 20 mM Tris-HCl) was applied to the column
and the flowthrough was collected and assayed for proline
dehydrogenase activity as previously described (Ref. 5). Af-
ter concentration in Centricon concentrators (Amicon) pro-
tein samples were dialyzed in G Buffer.
Only elution using L-Histidine yielded large quantities of
highly pure, active protein (Table 1). Imidazole and EDTA
yielded less pure protein and interfered with protein activ-
ity. Lowering the pH yielded very little functional protein.
In summary, the elution of proteins using the His·Tag
system is an empirical process.While a specific eluentmight
work for many proteins it will not work for all proteins.
Table 1. Purification of His·Tag PutA protein using
different elution schemes.
Proline
dehydrogenase
Elution conditions activitya Percent purityb
Imidazole elution 80 61%
pH elution >10 not determined
EDTA elution 1140 45%
Histidine elution 1800 87%
aProline dehydrogenase activity in nmol p-Iodonitrotetrazolium
(INT) reduced per minute per mg of protein, after various
purification schemes.
bPercent purity of PutA in various purification schemes. Analysis
performed using the public-domain NIH Image program
(developed at the U.S. National Institutes of Health, available on
the Internet at http://rsb.info.nih.gov/nih-image/).
Therefore, it could be advantageous to try several eluents
before deciding on the one that is optimal for a protein of
interest.
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Products Used
pET15b: pET15b from Novagen
Sure: Sure from Stratagene
SFCA filter: SFCA filter from Nalgene
HiTrap Metal Chelating column: HiTrap Metal
Chelating column from Pharmacia
FPLC: FPLC from Pharmacia
Centricon concentrators: Centricon concentra-
tors from Amicon Inc
Centricon concentrators: Centricon concentra-
tors from Amicon Inc
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